Small molecule · CNS / Anxiety

Buspirone

Buspar
Small moleculeSerotonin 5-HT1A receptor partial agonist (non-benzodiazepine anxiolytic)

PubChem CID 2477 · 3D model

Drag to rotate. Scroll or pinch to zoom.

Calms anxiety by partially activating a rather than boosting GABA the way benzodiazepines like diazepam and alprazolam do — slower to take effect, but without their sedation or dependence risk.

How it works

Buspirone works on a completely different brain target than benzodiazepines like diazepam and alprazolam, also on this site. Instead of boosting the calming chemical GABA, it partially activates a serotonin receptor called 5-HT1A, with some weaker action on dopamine receptors too. Because it doesn't touch the GABA system at all, it doesn't cause the drowsiness or the risk of dependence and withdrawal that come with benzodiazepines. The tradeoff is timing: it needs to be taken regularly for one to several weeks before its anti-anxiety effect kicks in, so it can't be used for quick, as-needed relief the way a benzodiazepine can.

What it’s used for

Buspirone is used to manage ongoing anxiety disorders and relieve anxiety symptoms, primarily generalized anxiety disorder. It is not approved for panic disorder the way some benzodiazepines, like alprazolam, are, and it isn't meant for everyday stress that doesn't rise to a diagnosable anxiety disorder.

Mechanism
Serotonin 5-HT1A receptor partial (non-benzodiazepine anxiolytic)
Drug class
Therapeutic area
CNS / Anxiety

Related drugs